Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: The whole genome sequencing of mule duck

PROVIDER: PRJNA1003295 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR25567419_subreads.fastq.gz	Fastqsanger.gz
	SRR25567420_subreads.fastq.gz	Fastqsanger.gz

Items per page:

1 - 2 of 2

Similar Datasets

Project description:Mule duck genome sequencing

| PRJNA1008272 | ENA

Real-time PCR analysis during mule duck development

Project description:This study proposes to describe the basal hepatic metabolism at the level of mRNA in mule duck embryos A kinetic study was designed to determine the level of expression of selected genes involved in liver metabolism throughout embryogenesis

2020-09-09 | GSE157687 | GEO

Anas platyrhynchos isolate:TC_2023

Project description:Mule duck haplotype 2 genome sequencing

| PRJNA1001158 | ENA

Anas platyrhynchos isolate:TC_2023

Project description:Mule duck haplotype 1 genome sequencing

| PRJNA1001159 | ENA

Real time PCR analysis during thermal manipulation in mule duck

Project description:This study proposes to describe impacts of an increase of temperature during embryogenesis by following hepatic metabolism at the level of mRNA in mule duck embryos Two kinetic studies were designed to determine the level of expression of selected genes involved in liver metabolism throughout embryogenesis and at hatch

2025-08-03 | GSE303902 | GEO

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:The transcriptome data for mule duck genome annotation

| PRJNA1001156 | ENA

Project description:Sequencing of liver tissue of force-feeding mule duck

| PRJNA816662 | ENA

Real-time PCR analysis during mule duck development

Project description:Real-time PCR analysis during mule duck development

| PRJNA662387 | ENA

ChemExpress

Project description:Targeted Oxford Nanopore sequencing of RARRES2 gene amplicons in mule duck

| PRJEB114134 | ENA